secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001213900-23-085393
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs amends ATM facility to allow up to $10M in common stock sales
-----------------------------------------------------------------------------

- Amended Equity Distribution Agreement with Maxim Group raises offering cap from $3.25M to $10M.
- Company previously sold the full $3.25M (11,065,416 shares) under the original agreement.
- Shares sold under the at-the-market offering; legal fees reimbursement to Maxim capped at $65,000.
- Offering registered on Form S-3; subject to one-third of non-affiliate market value limit per I.B.6.
- As of Nov 9, non-affiliate market value was ~$18M based on 21.2M shares and $0.85 close price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390023085393/0001213900-23-085393-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390023085393/ea187969-8k_hearttest.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-085393

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer